Pacira Pharmaceuticals Inc (PCRX) Insider Trading
- $1,566,107.90
- $211,656,685.81
- March 8, 2024
- Andreas Wicki
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 1, 2013 | Insider | 20,000 | $48.92 | Sell | $978,400.00 | |
| Sept. 11, 2013 | Director | 17,783 | $37.25 | Sell | $662,416.75 | |
| Aug. 14, 2013 | VP | 14,700 | $37.00 | Sell | $543,900.00 | |
| July 22, 2013 | Director | 75,958 | $35.06 | Sell | $2,663,087.48 | |
| July 18, 2013 | Director | 25,560 | $33.45 | Sell | $854,982.00 | |
| July 16, 2013 | Director | 48,482 | $33.28 | Sell | $1,613,480.96 | |
| July 12, 2013 | VP | 29,754 | $32.00 | Sell | $952,128.00 | |
| July 11, 2013 | Director | 80,000 | $31.48 | Sell | $2,518,400.00 | |
| July 5, 2013 | Director | 44,021 | $30.80 | Sell | $1,355,846.80 | |
| July 3, 2013 | Director | 114,448 | $30.21 | Sell | $3,457,474.08 | |
| July 2, 2013 | Insider | 40,000 | $29.44 | Sell | $1,177,600.00 | |
| June 28, 2013 | CFO | 10,000 | $28.05 | Sell | $280,500.00 | |
| June 28, 2013 | CEO | 15,000 | $28.73 | Sell | $430,950.00 | |
| June 28, 2013 | Director | 2,000 | $28.09 | Sell | $56,180.00 | |
| June 24, 2013 | Director | 75,900 | $29.13 | Sell | $2,210,967.00 | |
| June 20, 2013 | Director | 144,100 | $29.32 | Sell | $4,225,012.00 | |
| June 19, 2013 | Director | 35,407 | $29.90 | Sell | $1,058,669.30 | |
| June 17, 2013 | Director | 50,145 | $29.86 | Sell | $1,497,329.70 | |
| June 13, 2013 | Insider | 21,032 | $30.00 | Sell | $630,960.00 | |
| June 13, 2013 | Director | 22,746 | $30.07 | Sell | $683,972.22 | |
| June 12, 2013 | Director | 4,409 | $30.00 | Sell | $132,270.00 | |
| June 11, 2013 | Director | 11,500 | $30.00 | Sell | $345,000.00 | |
| June 11, 2013 | Insider | 18,343 | $30.00 | Sell | $550,290.00 | |
| June 5, 2013 | Director | 15,500 | $30.26 | Sell | $469,030.00 | |
| June 3, 2013 | Director | 1,900 | $30.00 | Sell | $57,000.00 | |
| May 31, 2013 | Director | 54,517 | $30.00 | Sell | $1,635,510.00 | |
| May 29, 2013 | Director | 215,528 | $30.86 | Sell | $6,651,194.08 | |
| May 22, 2013 | Director | 18,471 | $30.00 | Sell | $554,130.00 | |
| May 20, 2013 | Director | 14,374 | $30.00 | Sell | $431,220.00 | |
| March 25, 2013 | Director | 290,900 | $27.95 | Sell | $8,130,655.00 |
Insiders are both buying and selling Pacira Pharmaceuticals Inc stock.
The insider traders at Pacira Pharmaceuticals Inc are: Andreas Wicki, Lauren Bullaro Riker, David M Stack, Kristen Marie Williams, David M. Stack, Paul J Hastings, James S Scibetta, Max Reinhardt, Roy Winston, Gary W Pace, Charles A Reinhart III, John P Phd Longenecker, Mark A Kronenfeld, Gary Patou, Charles Anthony Laranjeira, Daryl Gaugler, Richard Scranton, Luke Evnin, Taunia Markvicka, John Pratt, Fred A Middleton, Scott Braunstein, Laura Brege, Mark Froimson, James B Jones, David Stack, James Scibetta, John Phd Longenecker, Anthony Molloy, Dennis L Winger, Donald C Manning, HASTINGS PAUL J, James B. Jones, James S. Scibetta, Jonathan Slonin, and Dennis Mcloughlin
The most active insider trader at Pacira Pharmaceuticals Inc is Andreas Wicki with 38 trades.
Andreas Wicki has sold the most Pacira Pharmaceuticals Inc stock with a total value of $103,301,745.13.
Gary W Pace has bought the most Pacira Pharmaceuticals Inc stock with a total value of $714,610.00.
The most recent insider trade for Pacira Pharmaceuticals Inc was on March 8, 2024.
The single biggest insider buy for Pacira Pharmaceuticals Inc was from James S Scibetta with a total value of $306,850.00 on Sept. 11, 2015.
The single biggest insider sell for Pacira Pharmaceuticals Inc was from Andreas Wicki with a total value of $15,187,500.00 on Aug. 11, 2014.